2/2/2026 2:00:38 PM Navigating the Future: 2026 Life Sciences Regulatory Outlook – Global Strategies for Tackling Escalating Cross-Border Challenges By Lincoln Tsang Kellie Combs Gregory Levine Joshua Oyster Katherine Wang +2 more... Show less On 20 January 2026, Ropes & Gray’s Global Life Sciences Regulatory & Compliance team hosted the “Life Sciences Regulatory Outlook 2026”...
9/9/2025 10:28:06 AM It's All Relative: Analysing The CJEU's Judgment On The Scope Of Pseudonymous Personal Data By Edward Machin David Peloquin In a decision with significant legal and operational ramifications for organisations of all shapes and sizes, the Court of Justice of the...
6/13/2025 12:55:37 PM What Are the Key Takeaways From Rachel Reeves’ Spending Review and Who Will be the Biggest Winners? By David Dowling Velyana Borisova Rachel Reeves, the UK’s Chancellor of the Exchequer, has revealed the Government’s Spending Review 2025 (SR25) setting out departmental...
6/2/2025 10:37:37 AM 2025 Medtech Regulatory Affairs Roundtable: Key Takeaways By Katherine Wang On May 22, Ropes & Gray and McKinsey & Company co-hosted the 12th Medtech Regulatory Affairs Roundtable online. Around 40 Regulatory...
5/30/2025 8:50:37 AM Regulation of Laboratory Developed Tests in APAC By Katherine Wang Michael Purcell Daisy Bray Laboratory Developed Tests (LDTs) are critical for diagnosing rare diseases and addressing unmet clinical needs. They are developed,...
5/12/2025 1:10:13 PM New Horizons: Implications of the UK-India Trade Agreement for Life Sciences and Innovation By Elizabeth Todd David Dowling Kenan Ceylan Fang Wei Chua +1 more... Show less The UK and India have announced one of the “biggest and most economically significant” bilateral trade agreements the UK has signed since...
4/23/2025 10:11:38 AM Regulatory Landscape for AI-enabled MedTech in APAC By Katherine Wang Michael Purcell Daisy Bray Regulation of artificial intelligence (AI) in Asia Pacific remains nascent, mostly governed by existing regulatory frameworks designed...
4/10/2025 9:18:37 AM Ruling of the Grand Chamber of the EU Court of Justice in Organic Food Labelling: International Trade-Related Implications By Lincoln Tsang Julie Kvedar Historical development on international trade cooperation on food products Since the early 1960s, countries representing over 99 per...
4/1/2025 6:41:36 AM China Formalizes Regulatory Data Protection Mechanism By Katherine Wang Recently, the National Medical Products Administration (NMPA) issued the draft version of 'Implementation Measures for Drug Trial Data...
3/26/2025 4:24:06 PM The Data Act: Six Months to Go — But What To Do? By Edward Machin The Financial Times recently published a special report on the future of digital healthcare, comprising articles on ‘smart’ hospitals,...
3/14/2025 9:26:37 AM Promoting Medical Device Regulatory Harmonization: Key Takeaways from the 27th IMDRF Conference in Japan By Katherine Wang The 27th International Medical Device Regulators Forum (IMDRF) conference, held this week in Japan, gathered regulators and industry...
3/12/2025 1:26:37 PM Addressing Supply Chain Vulnerabilities and Supply Shortages of Critical Essential Medicines: The Latest EU Legislative Proposal for a Critical Medicines Act By Lincoln Tsang Daisy Bray Challenges to global supply chain integrity for critical essential medicines The COVID-19 pandemic has heightened the focus on...
2/13/2025 10:15:06 PM ESG Compliance in 2025: A Curated Collection of Compliance Resources for Private Fund Managers and Portfolio Companies By Michael Littenberg ESG is integral to risk mitigation and value creation for most private fund managers and their portfolio companies. This year is likely...
2/6/2025 6:08:06 PM Life Sciences Regulatory Outlook 2025: Areas to Watch in the U.S., EU, UK, and Asia By Kellie Combs Lincoln Tsang Katherine Wang Joshua Oyster Daisy Bray Pascale Stain Emily Fruchterman +4 more... Show less As a new administration takes office in the U.S., life sciences companies and investors are preparing for changes in the regulatory,...
1/23/2025 8:39:07 AM China Tightens the Reins: Anti-Corruption Compliance Expectations for Companies in the Healthcare Sector By Andrew Dale Linghan Wang This month, as part of China’s ongoing anti-corruption campaign in the healthcare sector, the State Administration for Market Regulation...
1/14/2025 11:57:36 AM MHRA Launches the 2025 Pilot Real-World Evidence Dialogue Programme – Implementing Broader Data Strategy and Pro-Innovation Regulatory Framework By Lincoln Tsang Daisy Bray On 13 January 2025, the Medicines and Healthcare products Regulatory Agency (MHRA) launched its pilot Real-World Evidence (RWE)...